Friess Associates’s Bio-Techne TECH Stock Holding History

Friess Associates’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-567,144	Closed	-$28.9M	–	146
2018 Q3	$28.9M	Hold	567,144	–	–	2.02%	6
2018 Q2	$21M	Sell	567,144 -27,560	-5%	-$1.05M	1.66%	17
2018 Q1	$22.5M	Buy	594,704 +15,764	+3%	+$557K	1.83%	11
2017 Q4	$18.8M	Buy	578,940 +500	+0.1%	+$15.9K	1.55%	21
2017 Q3	$17.5M	Buy	578,440 +76,820	+15%	+$2.28M	1.53%	27
2017 Q2	$14.7M	Buy	+501,620	New	+$13.7M	1.34%	35

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Friess Associates's TECH Position: Q4 2018 in Review

Friess Associates sold out of Bio-Techne (TECH) in Q4 2018, closing a stake of 567,144 shares — an estimated $28.9M sold.

Friess Associates first reported a position in TECH in Q2 2017 and held it in 6 quarters. The position peaked at $28.9M in Q3 2018. 327 funds tracked by Wall St. Rank hold TECH as of Q4 2018.

Friess Associates reported no remaining Bio-Techne position as of Q4 2018 after selling out during the quarter.
Friess Associates sold 567,144 Bio-Techne shares in Q4 2018, an estimated $28.9M.
Friess Associates first reported a position in Bio-Techne in Q2 2017 and held it in 6 quarters.
Friess Associates's Bio-Techne position peaked at $28.9M in Q3 2018.
327 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2018.

Based on Friess Associates's 13F filing for Q4 2018, filed 14 Feb 2019.